Neurocode is a US-based, CAP-accredited, CLIA-certified laboratory that provides best-in-class neurological clinical testing. We specialize in neuroimmunology and neurodegenerative disease biomarker assays. Our commitment to the highest standards of quality, accuracy and reliability allows us to provide physicians with the best information available, empowering them to help improve patient outcomes. Our core mission is to bring cutting edge technologies to bear on neurological disorders through the development of novel diagnostic assays. We focus largely on rare autoimmune diseases, where the lack of robust diagnostic options is acutely felt, but lend our expertise to testing for a number of more common neurological conditions. Neurocode is a joint venture between BC Neuroimmunology Lab Inc. (Vancouver, BC, Canada) and Avero Diagnostics (Bellingham, WA), created to offer world-class neuroimmunology tests to clinicians across the U.S. and around the globe. BC Neuroimmunology Lab Inc. (BCNI) originated as UBC Neuroimmunology Laboratory in 1984 and was spun-off from the University of British Columbia in 2019. . BCNI services all of Canada with world-class neuroimmunology assays. Founded in 1987 as Northwest Pathology, Avero Diagnostics is a physician-owned pathology practice offering services in neuropathology and other pathology subspecialties throughout the United States.